During CUGH's Virtual Global Health Week, join the Pulitzer Center for a virtual workshop on communicating the global health impacts of cuts to U.S. foreign aid. Grantees Molly Knight Raskin, Ridwan Karim Dini-Osman, Joanne Cavanaugh Simpson, and Brian W. Simpson will review their recent reporting documenting the consequences of the cuts on health systems and communities’ well-being. Then, the panel will discuss how the story is being covered and science communication strategies to combat mis- and disinformation. Registration is required.
Panelists:
- Molly Knight Raskin is a freelance journalist who writes and produces for television, documentary films, and newspapers. For PBS NewsHour, Raskin reported on Cuts and Consequences: The End of USAID in collaboration with grantees William Brangham and Fred de Sam Lazaro. The project explores the impact of foreign aid freezes on global public health, with Raskin in particular investigating the immediate impact on several life-saving USAID programs in East and West Africa.
- Ridwan Karim Dini-Osman is a senior reporter and news presenter at the EIB Network (GHOne TV and StarrFM), and he is a freelance correspondent for the international radio news program The World. Dini-Osman reports on the consequences of cuts in Ghana in his projects Ghana Battles Deadly Meningitis Outbreak Amid Shrinking Foreign Aid and Health System Struggles and Malaria: New Infant Treatment and Shrinking Foreign Aid.
- Brian W. Simpson, editor-in-chief of Global Health NOW, and Joanne Cavanaugh Simpson, a freelance journalist and lecturer in the master’s in science writing program at Johns Hopkins University, highlight innovative responses from health workers in Uganda in their reporting for NPR, When the Money Goes Away: Saving Lives in Uganda and Beyond.
Ugandans pursue innovative health care strategies.
Project
Ghana Battles Deadly Meningitis Outbreak Amid Shrinking Foreign Aid and Health System Struggles
A deadly meningitis outbreak is sweeping through Ghana’s Upper West Region.
A new malaria drug offers hope just as U.S. aid cuts threaten progress in fighting the disease.